Media stories about Exactech (NASDAQ:EXAC) have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Exactech earned a daily sentiment score of 0.13 on Accern’s scale. Accern also assigned news coverage about the medical equipment provider an impact score of 44.5905027264122 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Several equities analysts have weighed in on the company. BidaskClub downgraded Exactech from a “sell” rating to a “strong sell” rating in a research report on Tuesday, January 30th. Robert W. Baird reissued a “hold” rating and set a $49.00 price target on shares of Exactech in a research report on Thursday, December 7th. Zacks Investment Research upgraded Exactech from a “sell” rating to a “hold” rating in a research note on Tuesday, December 26th. Finally, ValuEngine cut Exactech from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $49.00.
Exactech (EXAC) opened at $49.25 on Monday. Exactech has a fifty-two week low of $23.75 and a fifty-two week high of $50.95. The stock has a market capitalization of $707.53, a P/E ratio of 4,925.00, a P/E/G ratio of 3.66 and a beta of 0.90. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.08 and a quick ratio of 2.09.
Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.
Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.